Efficacy and safety of sabatolimab (MBG453) in combination with hypomethylating drugs (HMAs) in patients with very high or high risk myelodysplastic syndrome (vHR/HR-MDS) and acute myeloid leukemia (AML): final analysis after a phase Ib study

A. Brunner, K. Porkka,S. Knapper,E. Traer,S. Scholl, G. Garcia-Manero, N. Vey,M. Wermke, J. Janssen, R. Narayan, S. Loo,N. Tovar,M. Kontro,P. Naidu, M. Pelletier,D. Steensma, A. Lewandowski, N. Zhang, A. Mohammed,U. Borate, A. Wei

ONCOLOGY RESEARCH AND TREATMENT（2022）

引用 0|浏览16

暂无评分

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要